X2 Biosystems
Seattle, US · Founded 2010 · Washington corporation
Founders & leadership
JR
John RalstonChief Executive Officer
RA
Richard AbleExecutive
Board
RG
Robert G. RosenBoard director
CS
Chris SiegeBoard director
Reported raises · per SEC filings
Form D private placements$4.6M disclosed across 2 rounds · 2014–2015
▶$350KraisedApr 2015 · 3 investors · BiotechnologyRule 506(b)
▶$350KraisedApr 2015 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John RalstonExecutive Officer, Director
- Offering amount
- $350K
- Amount sold
- $350K
- First sale
- Mar 2015
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$4.2MraisedNov 2014 · 41 investors · BiotechnologyRule 506(b)
▶$4.2MraisedNov 2014 · 41 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard AbleExecutive Officer, Director
- Robert G. RosenDirector
- John RalstonExecutive Officer, Director
- Chris SiegeDirector
- Offering amount
- $9M
- Amount sold
- $4.2M
- Minimum investment
- $50K
- Sales commissions
- $330.6K
- Proceeds to insiders
- $140K
- Placement agents
- J.P. Turner & Company, L.L.C.
- First sale
- Apr 2014
- Incorporated
- Corporation, Washington, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has X2 Biosystems raised?
- X2 Biosystems has disclosed $4.6M raised across 2 rounds.
- Where is X2 Biosystems headquartered?
- X2 Biosystems is headquartered in Seattle, US.